Indrayani Biotech Limited (INDRANIB.BO)
INR 36.58
(0.38%)
INR 36.58
(0.38%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -478.83 Million | 161.87 Million | 41.11 Million | 2.55 Million | 59.58 Million | -2.07 Million |
| Net Income | 104.22 Million | 119.3 Million | 44.39 Million | -112.14 Million | 8.07 Million | -539.26 Thousand |
| Depreciation & Amortization | 38 Million | 33.47 Million | 6.59 Million | 4.58 Million | 10.14 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -621.06 Million | -51.14 Million | -28.52 Million | 69.46 Million | 30.27 Million | 71.92 Thousand |
| Other non-cash items | 371.24 Million | 60.23 Million | 18.64 Million | 40.65 Million | 11.09 Million | -1.61 Million |
| Investing Cash Flow | -5.5 Million | -473.93 Million | -5.58 Million | -7.02 Million | -36.65 Million | - |
| Investments in PPE | -164.87 Million | -434.14 Million | -12.07 Million | -6.95 Million | -34.86 Million | - |
| Acquisitions | 158.54 Million | -71.4 Million | -461 Thousand | 120 Thousand | 257.58 Thousand | - |
| Investment purchases | - | -2.22 Million | - | -1.71 Million | -90 Thousand | - |
| Sales/Maturities of investments | - | -123.8 Million | - | 1.43 Million | 478.79 Thousand | - |
| Other Investing Activities | 821 Thousand | 157.64 Million | 6.95 Million | 100 Thousand | -2.44 Million | - |
| Financing Cash Flow | 459.79 Million | 327.39 Million | -27.29 Million | -2.77 Million | -12.81 Million | 2.03 Million |
| Debt repayment | -449.18 Million | -448.57 Million | -13.68 Million | -16.9 Million | -1.51 Million | -418.94 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.09 Million | 232.81 Million | - | - | - | - |
| Other Financing Activities | 131.1 Million | 543.14 Million | -13.6 Million | 14.13 Million | -11.3 Million | 2.44 Million |
| Accounts receivables | -140.39 Million | -158.73 Million | -93.32 Million | 22.76 Million | 8.89 Million | - |
| Accounts payables | 146.52 Million | 169.18 Million | 24.77 Million | -28.35 Million | 12.9 Million | - |
| Inventory | -301.36 Million | -106.81 Million | -4.43 Million | 39.82 Million | 34.49 Million | - |
| Other working capital | -325.82 Million | 45.22 Million | 44.45 Million | 35.23 Million | -26.01 Million | 71.92 Thousand |
| Cash at beginning of period | 30.36 Million | 15.03 Million | 6.8 Million | 14.02 Million | 3.91 Million | 104.6 Thousand |
| Cash at end of period | 5.82 Million | 30.36 Million | 15.03 Million | 6.78 Million | 14.02 Million | 56.2 Thousand |
| Capital Expenditure | -164.87 Million | -434.14 Million | -12.07 Million | -6.95 Million | -34.86 Million | - |
| Effect of forex changes on cash | - | - | - | 1000.00 | -1.00 | - |
| Net cash flow / Change in cash | -24.54 Million | 15.33 Million | 8.23 Million | -7.23 Million | 10.1 Million | -48.4 Thousand |
| Free Cash Flow | -643.7 Million | -272.26 Million | 29.03 Million | -4.39 Million | 24.72 Million | -2.07 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.5 Million | 1.23 Million | 104.22 Million | 10.82 Million | 55.42 Million | -4.45 Million |
| Depreciation & Amortization | - | - | 38 Million | 10.34 Million | 9.08 Million | 8.98 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -621.06 Million | - | - | - |
| Other non-cash items | -8.5 Million | -1.23 Million | 371.24 Million | -10.82 Million | -55.42 Million | 4.45 Million |
| Investing Cash Flow | - | - | -5.5 Million | - | - | - |
| Investments in PPE | - | - | -164.87 Million | - | - | - |
| Acquisitions | - | - | 158.54 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 821 Thousand | - | - | - |
| Financing Cash Flow | - | - | 459.79 Million | - | - | - |
| Debt repayment | - | - | -449.18 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 19.09 Million | - | - | - |
| Other Financing Activities | - | - | 131.1 Million | - | - | - |
| Accounts receivables | - | - | -140.39 Million | - | - | - |
| Accounts payables | - | - | 146.52 Million | - | - | - |
| Inventory | - | - | -301.36 Million | - | - | - |
| Other working capital | - | - | -325.82 Million | - | - | - |
| Cash at beginning of period | - | - | 30.36 Million | 5.8 Million | -49.62 Million | 30.36 Million |
| Cash at end of period | - | - | 5.82 Million | 26.48 Million | 5.8 Million | -4.45 Million |
| Capital Expenditure | - | - | -164.87 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -24.54 Million | 20.68 Million | 55.42 Million | -34.82 Million |
| Free Cash Flow | - | - | -643.7 Million | 20.68 Million | 55.42 Million | -4.45 Million |
001206
CRNZF
YKEN
ALMAS
PDPTF
1AD